Evidence map›Paper›PMID 11849189›Full record

ReviewBritish journal of clinical pharmacology2002

Pharmacogenetics of asthma.

A Fenech, Ian P Hall

Abstract readReview
In one paragraph

Review in British journal of clinical pharmacology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2014
    Article
  4. Review
  5. The role of pharmacogenetics and pharmacogenomics in improving translational medicine.Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases · 2009
    Article
  6. Article
  7. Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  8. Pharmacogenetic approaches in the treatment of asthma.Current allergy and asthma reports · 2005
    Review
  9. Review
  10. Beta-adrenoceptor polymorphisms.Naunyn-Schmiedeberg's archives of pharmacology · 2004
    Review
  11. 6. Asthma.The Journal of allergy and clinical immunology · 2003
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

A FenechDepartment of Clinical Pharmacology and Therapeutics, University of Malta, Msida MSD 06, Malta.
Ian P Hall

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in the extent of knowledge regarding interindividual genetic variation in drug treatment targets and drug metabolizing enzymes has resulted in studies designed to assess the contribution of genetic variability to treatment response in a range of diseases. This review describes the current state of knowledge of genetic variability in key airway targets important in the treatment of asthma. Whilst the genes coding for some key treatment targets contain little polymorphic variation (e.g. the muscarinic M2 and M3 receptors) other genes whose products are important targets in the treatment of asthma contain extensive genetic variation. The best examples of the latter are the beta2-adrenoceptor and the 5-lipoxygenase genes. Genetic variability in both of these genes may account in part for interindividual variability in treatment response. Finally, a number of key targets within the airways remain to be adequately screened for polymorphic variation.

Indexed as

Amino Acid SequenceAnimalsAsthmaGenetic Predisposition to DiseaseGenetic VariationGenotypeHumansMolecular Sequence DataPolymorphism, GeneticReceptors, Adrenergic, beta-2Receptors, Adrenergic, beta-2

Identifiers

PMID11849189
PMCPMC1874556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.